Company
United StatesPublic company, NASDAQ: LINLinde, Inc. (NASDAQ: LIN), La Porte, IN – FDA Inspections
Inspection records and compliance data for Linde, Inc. in La Porte, Indiana. 2 FDA inspections on record, 1 Form 483, last inspected March 11, 2026. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde, Inc. based in La Porte, Indiana, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected July 22, 2014. Last inspected March 11, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 11, 2026 | Not classified | Human Drugs | 1306826 |
| July 22, 2014 | NAI | Human Drugs · Drug Quality Assurance | 888045 |
FDA documents
Form 483s (1)
Other regulators (1)
- Health Canada · 1 inspection · last May 22, 2018
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde, Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$522.49
Market cap
$239.9B
Price as of
November 13, 2026
FEI Number
1832669
Address
3076 N State Road 39, La Porte, Indiana 46350, United States
Country
United States
ID: 367ae011-fc03-4eb2-affa-2fc797ec78aa